One of the most distressing aspects of Alzheimer’s disease is that there is no cure. But a new drug is showing promise as an effective treatment that slows down the disease’s debilitating effects.
Older people who are not depressed, but have symptoms of apathy, may have a higher risk of developing brain changes linked to dementia, says a new study. Alzheimer’s disease is the most common type of dementia.
For the more than 6 million Americans who are living with Alzheimer’s, holding on to a memory is not a choice. Unless we find a cure, or stop the progression, projections indicate that by 2050 there could be as many as 16 million people living with Alzheimer’s.
A new study finds that Alzheimer’s disease may contribute to almost as many deaths as heart disease or cancer. The researchers say their results would mean that Alzheimer’s disease contributes to more than 500,000 deaths each year.
There is so much information swirling around about statins that it's no surprise that patients don't know what to believe. Find the facts about this commonly prescribed but often misunderstood drug.
As we age, problems with memory and thinking become common. But a new study shows that for those who have developed atrial fibrillation — a type of irregular heartbeat — these problems may come on more quickly.
Dementia doesn’t always bring memory and language problems. Frontotemporal dementia affects inhibition and judgment, and it usually strikes men in mid-life, so it’s often mistaken for a mid-life crisis.
Creutzfeldt-Jakob Disease (CJD) is a neuro-degenerative illness with a rapid onset and decline. In some cases, it can be hereditary, so when CJD strikes a family, genetic counseling is suggested.
We’ve all heard of the forgetfulness and language problems that can signal Alzheimer’s. But when this disease strikes adults under 65, it can arrive with unexpected and puzzling symptoms – like unexplained clumsiness.
In memory of her mother who struggled with Alzheimer’s disease, a runner competes in an ultra marathon: a 100-mile race to raise money for Alzheimer’s research.